Skip to content

ACADIA Pharmaceuticals announced , it no longer needs to conduct additional Phase III trials for its pimavanserin drug for the treatment of Parkinson’s disease psychosis

April 12, 2013

New Drug Approvals

cas no 706779-91-1
706782-28-7 (tartrate)

11, april 2013

ACADIA Pharmaceuticals announced following its FDA meeting, it no longer needs to conduct additional Phase III trials for its pimavanserin drug for the treatment of Parkinson’s disease psychosis. The company plans to seek early approval for the drug.

ACADIA Pharmaceuticals Inc.  announced that the FDA has agreed that the data from the pivotal Phase III -020 study, together with supportive data from other studies with pimavanserin, are sufficient to support the filing of a New Drug Application, or NDA, for the treatment of Parkinson’s disease psychosis, or PDP. ACADIA will no longer conduct the Phase III -021 study that was planned as a confirmatory trial. ACADIA believes FDA decision will reduce substantially both the time and cost of the company’s PDP development program.

ACADIA is currently focused on completing the remaining elements of its pimavanserin PDP development program that are needed for…

View original post 389 more words


From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Green Chemistry @ MUN

Less solvent, Less waste, Less energy

Lyra Nara Blog

modern holistic medicine, bioenergy devices, create your healthy journey

Developing the Process

Selected papers for the Process Development Chemist

Anthony Crasto's Transverse Mylitis Blog

Medicinal chemistry clips for you

Inspiring Science

Casting light on great ideas

News and articles on the Pharmaceutical Industry

Colorblind Chemistry

Organometallic Chemistry with a Vengeance.

Metta Wellness

Where Massage and Wellness come together to create Balance of Mind, Body, Spirit ,


A great site


Total Synthesis and general organic chemistry

Your mom is like science?

Practical scientific analogy education and outreach


in English

RecallsDirect™ by Living Safely™

Official Site - An initiative of™, we report on food, product and vehicle recalls from various agencies in US, Canada, Europe and other jurisdictions.

TGI: Thrive Health

Share Knowledge & Save a Life


Drug Regulatory affairs by DR ANTHONY MELVIN CRASTO, Worlddrugtracker

Seven Spheres

Aqua Terra Ignis et Aer


Green Chemistry Awesomeness.

%d bloggers like this: